ROSEN, A LEADING LAW FIRM, Encourages ESSA Pharma Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - EPIX
Portfolio Pulse from
Rosen Law Firm is urging investors of ESSA Pharma Inc. (NASDAQ:EPIX) who purchased securities between December 12, 2023, and October 31, 2024, to secure legal counsel before the March 25, 2025, deadline for a securities class action.
March 07, 2025 | 9:15 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
ESSA Pharma Inc. is involved in a securities class action lawsuit, with a lead plaintiff deadline on March 25, 2025. Investors who purchased during the specified period may be entitled to compensation.
The involvement in a securities class action lawsuit typically has a negative impact on a company's stock price due to potential legal liabilities and associated costs. The deadline for lead plaintiff suggests ongoing legal proceedings, which can create uncertainty for investors.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100